Jobs at the Center for Biologics Evaluation and Research (CBER)
CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics. Employment opportunities offer competitive salaries and excellent benefits. We invite you to apply for one of the positions listed below if you are seeking a challenging career opportunity.
Browse all FDA CBER positions on USAJOBS
For general information on qualifications for Medical Officers, scientists (Biologist, Chemist, Microbiologist, etc.), Consumer Safety Officers and other positions, please visit FDA’s Career Descriptions page.
CBER positions (other than those listed on USAJobs)
- CBER Title 21 Vacancy Announcement – Deputy Division Director, AD–Band E, Office of Biostatistics and Pharmacovigilance (OBPV), Division of Analytics and Benefit-Risk Assessment (DABRA)
Closes: May 15, 2024 - CBER Title 21 Vacancy Announcement – Branch Chief, AD–Band D, Office of Biostatistics and Pharmacovigilance (OBPV), Division of Analytics and Benefit-Risk Assessment (DABRA), Benefit-Risk Assessment Branch (BRAB)
Closes: May 15, 2024 - CBER Title 21 Vacancy Announcement – Branch Chief, Band D, Office of Biostatistics and Pharmacovigilance (OBPV), Division of Analytics and Benefit-Risk Assessment (DABRA), Analytics and RWE Branch (ARWEB)
Closes: May 15, 2024 - Staff Fellow/Visiting Associate – Interdisciplinary Scientist
Closes: May 17, 2024 - CBER Title 21 Vacancy Announcement – Information Technologist (Enterprise Architect), AD-2210 – Band F, Office of Regulatory Operations (ORO), Immediate Office of the Director (IOD)
Closes: May 21, 2024 - CBER Title 21 Vacancy Announcement – Lead Clinical Laboratory Scientist, AD-0644-Band D, Office of Blood Research and Review (OBRR), Division of Blood Components and Devices (DBCD), Devices Review Branch (DRB)
Closes: May 22, 2024 - CBER Title 21 Vacancy Announcement – Deputy Division Director, AD-0601 - Band E, Office of Vaccines Research and Review (OVRR), Division of Bacterial Parasitic and Allergenic Products (DBPAP)
Closes: May 22, 2024 - CBER Title 21 Vacancy Announcement - Science Disclosure Analyst, AD-0401-Bands A/B, Office of Communication Outreach and Development (OCOD), Division of Disclosure and Oversight Management (DDOM)
Closes: May 29, 2024 - Staff Fellow/Visiting Associate – Pharmacology/Toxicology Reviewer
Closes: June 30, 2024 - CBER Title 21 Vacancy Announcement – Physician, AD-Band C, Office of Therapeutic Products (OTP), Office of Clinical Evaluation (OCE), Division of Clinical Evaluation General Medicine (DCEGM), General Medicine Branch (GMB)
Closes: July 1, 2024 - CBER Title 21 Vacancy Announcement – Physician, Band C, Center for Biologics Evaluation and Research (CBER), Office of Biostatistics and Pharmacovigilance (OBPV), Division of Pharmacovigilance (DPV)
Open continuously - CBER Cures Vacancy Announcement – Physician, AD-0602-Band C, Office of Therapeutic Products (OTP)
Open continuously - CBER Title 21 Vacancy Announcement– Physician, AD-0602-Band C, Office of Vaccines Review and Research (OVRR), Division of Clinical and Toxicology Review (DCTR)
Open continuously
Fellowship Programs
- National Cancer Institute (NCI) and FDA Interagency Oncology Task Force (IOTF) Joint Fellowship Program
Offers fellowship training to a cadre of scientists in research and research-related regulatory review, policies, and regulations to develop a skill set bridging two distinct processes. - Oak Ridge Institute for Science and Education (ORISE) Research Participation Training Program for CBER
Provides temporary scientific training for domestic and foreign scientists having a background or interest in medical, biological, chemical, toxicological, mathematical/statistical, or other related sciences.
Related Information
- America's Veteran
- Hiring Programs
- Jobs at FDA
- Pathways Program (for students and recent graduates)
- 2024 Salary Tables and Related Information